US OptionsDetailed Quotes

NVCR241115P29000

Watchlist

0.00
0.000.00%

15min DelayNot Open Nov 6 09:30 ET

0.00High0.00Low

Novocure Stock Discussion

EZ_money

4 hours ago

$Novocure (NVCR.US)$ 👀seems like wallstreet likes this stock favoring another higher PT.
$Moderna (MRNA.US)$ $Emergent BioSolutions (EBS.US)$ $BioLife Solutions (BLFS.US)$

EZ_money

Oct 21 04:46

$Novocure (NVCR.US)$ 20 LFG 💪

EZ_money

Oct 18 14:38

$Novocure (NVCR.US)$ now this i can respect 🤑

EZ_money

Oct 18 13:38

$Novocure (NVCR.US)$ what?

EZ_money

Oct 18 04:08

$Novocure (NVCR.US)$ 👈 great news out 👍
$Clover Health (CLOV.US)$ $Moderna (MRNA.US)$ $Astera Labs (ALAB.US)$

104876179

Oct 17 09:30

Felt scammed

$Novocure (NVCR.US)$ … why keeps dropping… might as well don’t publish the good news…

EZ_money

Oct 17 03:48

$Rockwell Medical (RMTI.US)$👈 daily MACD convergence crossover coming bullish trend
$Novocure (NVCR.US)$ $Moderna (MRNA.US)$ $Clover Health (CLOV.US)$

Stock_Drift

Oct 15 17:20

$Novocure (NVCR.US)$

Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment

Jerry Kronenberg

Oct 15 15:56

Columns Biotech Firm Novocure Soars Some 40% After Hours After FDA Approves Anti-Cancer Device

$Novocure (NVCR.US)$ biotech firm shot up some 40% after hours Tuesday after the Swiss biotech announced that U.S. regulators have approved its Optune Lia device for treatment of metastatic non-small cell lung cancer.
NVCR gained 39.9% to $24.88 shortly before 5 p.m. ET on word of the U.S. Food and Drug Administration's acceptance of Optune Lia.
The FDA OK'd the product's use with PD-1/PD-L1 inhibitors or docet...

No comment yet